Huntsman Cancer Institute is an NCI-designated cancer research facility and hospital located on the campus of the University of Utah in Salt Lake City, Utah. It is the only National Cancer Institute-designated Comprehensive Cancer Center in the Intermountain West.

During the past decade, Huntsman cancer Institute conducted 548 clinical trials. In the 10-year time frame, 548 clinical trials started and 288 clinical trials were completed, i.e. on average, 52.6% percent of trials that started reached the finish line to date. In the past 5 years, 189 clinical trials started and 126 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Huntsman cancer Institute" #1 sponsor was "National Cancer Institute (NCI)" with 170 trials, followed by "University of Utah" with 147 trials sponsored, "SWOG Cancer Research Network" with 120 trials sponsored, "Alliance for Clinical Trials in Oncology" with 37 trials sponsored and "Children's Oncology Group" with 37 trials sponsored. Other sponsors include 601 different institutions and companies that sponsored additional 245 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Huntsman cancer Institute" #1 collaborator was "National Cancer Institute (NCI)" with 366 trials as a collaborator, "NRG Oncology" with 56 trials as a collaborator, "SWOG Cancer Research Network" with 25 trials as a collaborator, "Cancer and Leukemia Group B" with 20 trials as a collaborator and "Merck Sharp & Dohme LLC" with 20 trials as a collaborator. Other collaborators include 465 different institutions and companies that were collaborators in the rest 236 trials.

According to Clinical.Site data, the most researched conditions in "Huntsman cancer Institute" are "Breast Cancer" (56 trials), "Leukemia" (37 trials), "Melanoma" (36 trials), "Cancer" (32 trials) and "Lung Cancer" (32 trials). Many other conditions were trialed in "Huntsman cancer Institute" in a lesser frequency.

Most popular intervention types in "Huntsman cancer Institute" are "Drug" (887 trials), "Other" (246 trials), "Biological" (243 trials), "Radiation" (190 trials) and "Procedure" (181 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (99 trials), "Quality-of-Life Assessment" (76 trials), "Nivolumab" (68 trials), "Placebo" (61 trials) and "Questionnaire Administration" (55 trials). Other intervention names were less common.

The vast majority of trials in "Huntsman cancer Institute" are 927 trials for "All" genders, 127 trials for "Female" genders and 60 trials for "Male" genders.

Currently, there are NaN active trials in "Huntsman cancer Institute". 3 are not yet recruiting, 213 are recruiting, 234 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 499 completed trials in Huntsman cancer Institute, 13 suspended trials, and 120 terminated clinical trials to date.

Out of the total trials that were conducted in Huntsman cancer Institute, 280 "Phase 1" clinical trials were conducted, 529 "Phase 2" clinical trials and 314 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 60 trials that are defined as “Not Applicable".